Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Catalyst Biosciences Inc (CBIO)
NASDAQ:CBIO
Catalyst Biosciences (CBIO) Stock Price & Analysis
752 Followers
CBIO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.19 - $0.40
Previous Close$0.23
Volume96.95K
Average Volume (3M)239.37K
Market Cap
$9.06M
Enterprise Value$963.36K
Total Cash (Recent Filing)$8.10M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)0.6
Beta3.02
Next Earnings
Aug 03, 2023EPS Estimate
-$0.07Last Dividend Ex-Date
Jan 13, 2023Dividend Yield
3.1 (1289.34%)Share Statistics
EPS (TTM)0.42
Shares Outstanding30,782,924
10 Day Avg. Volume211,394
30 Day Avg. Volume239,365
Standard Deviation1.31
R-Squared0.05
Alpha0.20
Financial Highlights & Ratios
Price to Book (P/B)-0.34
Price to Sales (P/S)74.91
Price to Cash Flow (P/CF)-0.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue10.03
Enterprise Value/Gross Profit-240.84
Enterprise Value/Ebitda-0.02
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering1
Catalyst Biosciences News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CBIO FAQ
What was Catalyst Biosciences Inc’s price range in the past 12 months?
Catalyst Biosciences Inc lowest stock price was $0.19 and its highest was $0.40 in the past 12 months.
What is Catalyst Biosciences Inc’s market cap?
Currently, no data Available
When is Catalyst Biosciences Inc’s upcoming earnings report date?
Catalyst Biosciences Inc’s upcoming earnings report date is Aug 03, 2023 which is in 56 days.
How were Catalyst Biosciences Inc’s earnings last quarter?
Catalyst Biosciences Inc released its earnings results on May 04, 2023. The company reported $0.01 earnings per share for the quarter, the consensus estimate of $0.01 by $0.
Is Catalyst Biosciences Inc overvalued?
According to Wall Street analysts Catalyst Biosciences Inc’s price is currently Overvalued.
Does Catalyst Biosciences Inc pay dividends?
Catalyst Biosciences Inc pays a Annually dividend of $0.24 which represents an annual dividend yield of N/A. See more information on Catalyst Biosciences Inc dividends here
What is Catalyst Biosciences Inc’s EPS estimate?
Catalyst Biosciences Inc’s EPS estimate is -$0.07.
How many shares outstanding does Catalyst Biosciences Inc have?
Catalyst Biosciences Inc has 37,759,827 shares outstanding.
What happened to Catalyst Biosciences Inc’s price movement after its last earnings report?
Catalyst Biosciences Inc reported an EPS of $0.01 in its last earnings report, expectations of $0.01. Following the earnings report the stock price went up 4.762%.
Which hedge fund is a major shareholder of Catalyst Biosciences Inc?
Currently, no hedge funds are holding shares in CBIO
---
Catalyst Biosciences Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
― (―)
― (―)
Blogger Sentiment
Bullish
CBIO Sentiment 100%
Sector Average 71%
Sector Average 71%
Crowd Wisdom
Negative
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 0.2%
Last 30 Days ▼ 0.2%
Technicals
SMA
Negative
20 days / 200 days
Momentum
22.63%
12-Months-Change
Fundamentals
Return on Equity
38.06%
Trailing 12-Months
Asset Growth
-53.44%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Catalyst Biosciences Inc
Catalyst Biosciences, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions. The company was founded on August 20, 2015 and is headquartered in South San Francisco, CA.
---
Top 5 ETFs holding CBIO
iShares Core S&P Total U.S. Stock Market ETF
$1.64K
Up to five ETFs with an Outperform Smart Score that hold CBIO. The ETFs are listed according to market value of CBIO within the ETF
---
---